Home > Insider Trading > Filing (0001181431-10-052253)

Filing Details

Accession Number:: 0001181431-10-052253
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-10-27 13:00:00
Reporting Period:: 2010-10-27

Filing Date:: 2010-10-27
Accepted Time:: 2010-10-27 17:46:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1338042	Aegerion Pharmaceuticals Inc.	AEGR	Pharmaceutical Preparations (2834)	202960116

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1402023	L.p. (Delaware) Iii Ventures Index	No. 1 Seaton Place St. Helier Y9 JE4 8YJ	No	No	Yes	No
1447764	Branch Jersey L.p. Partners Yucca	The Ogier House, The Esplanade St, Helier, Channel Islands Y9 JE4 9WG	No	No	Yes	No
1503681	L.p. (Jersey) Fund Entrepreneur Parallel Iii Ventures Index	No. 1 Seaton Place St. Helier Y9 JE4 8YJ	No	No	Yes	No
1503683	Ltd Iii Associates Venture Index	No. 1 Seaton Place St. Helier Y9 JE4 8YJ	No	No	Yes	No
1503686	L.p. (Jersey) Iii Ventures Index	No. 1 Seaton Place St. Helier Y9 JE4 8YJ	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-10-27	1,367,346	$0.00	1,367,346	No	4	C	Indirect	See Footnotes
Common Stock	Acquisiton	2010-10-27	477,723	$0.00	1,845,069	No	4	C	Indirect	See Footonotes
Common Stock	Acquisiton	2010-10-27	881,128	$7.60	2,726,197	No	4	C	Indirect	See Footonotes
Common Stock	Acquisiton	2010-10-27	315,789	$9.50	3,041,986	No	4	P	Indirect	See Footonotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnotes
No	4	C	Indirect	See Footonotes
No	4	C	Indirect	See Footonotes
No	4	P	Indirect	See Footonotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2010-10-27	3,533,095	$0.00	1,367,346	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2010-10-27	782,801	$0.00	477,723	$0.00
Common Stock	Senior Subordinated Convertible Promissory Notes	Disposition	2010-10-27	0	$0.00	881,128	$7.60

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
	No	4	C	Indirect
	No	4	C	Indirect
2011-12-31	No	4	C	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,046,158	Indirect	See Footnotes

Footnotes

These securities are owned directly by Index Ventures III (Jersey), L.P. ("IVIII Jersey"), Index Ventures III (Delaware), L.P. ("IVIII Delaware") and Index Ventures Parallel Entrepreneur Fund (Jersey) ("IVPEF"), of which Index Venture Associates III Limited is the general partner and by Yucca Partners L.P. (Jersey Branch) as Administrator of the Index Co-Investment Scheme ("Yucca"). Michele Ollier, Director of the Issuer, is a partner of the Index Ventures. Index Venture Associates III Limited and Dr. Ollier disclaim beneficial ownership of all such shares held by the foregoing funds, except to the extent of their proportionate pecuniary interest therein.
Upon the closing of the Issuer's initial public offering on October 27, 2010, each share of Series A Convertible Preferred Stock (the"Series A Shares") and each share of the Series B Convertible Preferred Stock (the "Series B Shares"), plus accrued dividends, immediately converted into shares of common stock of the Issuer in accordance with the terms of the Issuer's Third Amended and Restated Certificate of Incorporation. The Series A Shares coverted on a 1-for-0.38701117412 basis and the Series B Shares converted on a 1-for-0.6102765793 basis. The Series A Shares and the Series B Shares were convertible at any time, at the holder's election, and automatically upon consummation of the Issuer's initial public offering and had no expiration date.
IVIII Jersey is the direct beneficial owner of 444,181 shares of common stock issued upon the conversion of its Series A Shares and 153,242 shares of common stock issued upon the conversion of its Series B Shares; IVIII Delaware is the direct beneficial owner of 902,307 shares of common stock issued upon the conversion of its Series A Shares and 311,294 shares of common stock issued upon the converion of its Series B Shares; IVPEF is the direct beneficial owner of 16,073 shares of common stock issued upon the conversion of its Series A Shares and 5,544 shares of common stock issued upon the conversion of its Series B Shares; and Yucca is the direct beneficial owner of 4,785 shares of common stock issued upon the conversion of its Series A Shares and 7,643 shares of common stock issued upon the conversion of its Series B Shares.
The outstanding principal and accrued and unpaid interest on these senior subordinated convertible promissory notes (the "Convertible Notes") automatically converted into shares of common stock upon the closing of the Issuer's initial public offering, at $7.60 per share, 80% of the Issuer's initial public offering price per share.
IVIII Jersey is the direct beneficial owner of 285,307 shares of common stock issued upon the conversion of its Convertible Notes; IVIII Delaware is the direct beneficial owner of 579,571 shares of common stock issued upon the conversion of its Convertible Notes; IVPEF is the direct beneficial owner of 10,320 shares of common stock issued upon the conversion of its Convertible Notes; and Yucca is the direct beneficial owner of 5,930 shares of common stock issued upon the conversion of its Convertible Notes.
Shares acquired upon the closing of the Issuer's initial public offering at the initial public offering price of $9.50 per share.
IVIII Delaware is the direct beneficial owner of 315,789 shares of common stock of the Issuer.
IVII Jersey is the direct beneficial owner of 1,356 shares of common stock of the Issuer; IVIII Delaware is the direct beneficial owner of 2,754 shares of common stock of the Issuer; IVPEF is the direct beneficial owner of 48 shares of common stock of the Issuer; and Yucca is the direct beneficial owner of 14 shares of common stock of the Issuer.